icon

Roivant Sciences Ltd. (ROIV)

Pharmaceutical Preparations

Insiders

Type of OwnerSecurities OwnedAs Insider in other CompaniesDate Last Transaction
10%own102,849,44312022-11-10
Director by Deputization65,793,77912024-09-25
10%own52,532,46812025-05-06
Dir28,624,69612024-09-24
Pres&Chief Investment Officer, Dir18,836,54702024-12-23
Dir, CEO17,283,76612025-05-20
Dir1,277,17812024-09-24
Roivant Health, President1,167,49102021-09-21
President, COO1,077,19722025-05-20
CFO402,21202025-05-20
CAO162,30612025-02-20
CAO112,25502025-03-20
Dir102,50002025-04-17
Dir95,71022025-04-17
Dir52,14222022-09-15
Dir41,37622025-04-17
Dir29,37622024-09-12
Dir092021-09-21
Dir002022-09-06
Dir002021-09-21

*: Insider is not longer subject to Section 16

Securities owned over time

JunJulAugSepOctNovDecJanFebMarAprMay020M40M60M80M100M• Dexcel Pharma Technologies Ltd.• Qvt Financial Lp• Ramaswamy Vivek• Gold Daniel Allen• Sukhatme Mayukh• Gline Matthew• Manchester Keith S• Zimmer Benjamin• Venker Eric• Pulik Richard• Kumar Rakhi• Humes Jennifer• Oren Ilan• Momtazee James C• Lo Andrew• Epperly Melissa B,• Fitzgerald Meghan• Machado Patrick• Nomura Hiroshi• Tada Masayo−20M020M−50M050MΔ SecuritiesΔ Cash

Recent trades

Transaction DateInsiderTitleFormTrade TypesΔ SecuritiesΔ CashOwned
2025-05-20Pulik RichardCFO4F−3,487$0402.21K
2025-05-20Venker EricPresident, COO4F, M, S−39,148$710K1.08M
2025-05-20Gline MatthewDir, CEO4F−10,945$017.28M
2025-05-06Ramaswamy Vivek10%own4S−898,959$10.1M52.53M
2025-04-28Pulik RichardCFO4F−1,653$0405.7K
2025-04-21Pulik RichardCFO4A141,464$0407.35K
2025-04-20Venker EricPresident, COO4F, M, S−10,945$637K1.12M
2025-04-20Gline MatthewDir, CEO4F−10,945$017.29M
2025-04-17Epperly Melissa B,Dir4A1,847$041.38K
2025-04-17Momtazee James CDir4A, F1,103$095.71K
2025-04-17Oren IlanDir4A, F2,571$0102.5K
2025-03-28Pulik RichardCFO4F−1,653$0265.89K
2025-03-20Venker EricPresident, COO4F, M, S241,366$4.3M1.13M
2025-03-20Humes JenniferCAO4A112,255$0112.26K
2025-03-20Pulik RichardCFO4F−1,504$0267.54K
2025-03-20Gline MatthewDir, CEO4F−10,945$017.31M
2025-02-28Pulik RichardCFO4F−1,635$0269.05K
2025-02-20Kumar RakhiCAO4F−958$0162.31K
2025-02-20Gline MatthewDir, CEO4F−10,945$017.32M
2025-02-20Venker EricPresident, COO4F, M, S−10,945$680K885.92K
2025-02-13Kumar RakhiCAO4M, S−40,000$1.7M163.26K
2025-02-12Venker EricPresident, COO4M, S164,575$2.3M896.87K
2025-02-09Humes JenniferCAO30$00
2025-01-28Pulik RichardCFO4F−1,896$0270.68K
2025-01-23Ramaswamy Vivek10%own4G0$053.43M
2025-01-23Epperly Melissa B,Dir4A, F1,492$039.53K
2025-01-23Momtazee James CDir4A, F942$094.61K
2025-01-23Oren IlanDir4A, F2,073$099.93K
2025-01-20Kumar RakhiCAO4F−1,057$0203.26K
2025-01-20Venker EricPresident, COO4F, M, S−8,682$743K732.29K
2025-01-20Gline MatthewDir, CEO4F−11,623$017.33M
2024-12-28Pulik RichardCFO4F−1,896$0272.58K
2024-12-27Venker EricPresident, COO4M, S145,396$2.2M740.98K
2024-12-23Sukhatme MayukhPres&Chief Investment Officer, Dir4M, S0$7.2M18.84M
2024-12-20Pulik RichardCFO4F−2,129$0274.47K
2024-12-20Kumar RakhiCAO4F−3,087$0204.32K
2024-12-20Venker EricPresident, COO4F, M, S−10,945$764K595.58K
2024-12-20Gline MatthewDir, CEO4F−10,945$017.34M
2024-12-18Sukhatme MayukhPres&Chief Investment Officer, Dir4M, S0$3.4M18.84M
2024-12-03Sukhatme MayukhPres&Chief Investment Officer, Dir4J−3,651,985$44.6M18.84M
2024-11-28Pulik RichardCFO4F−2,341$0276.6K
2024-11-20Kumar RakhiCAO4F−958$0207.41K
2024-11-20Venker EricPresident, COO4F, M, S−10,945$747K606.53K
2024-11-20Gline MatthewDir, CEO4F−10,945$017.35M
2024-10-28Pulik RichardCFO4F−2,341$0278.94K
2024-10-21Momtazee James CDir4A1,231$093.67K
2024-10-21Epperly Melissa B,Dir4A1,613$038.04K
2024-10-21Oren IlanDir4A2,303$097.86K
2024-10-20Venker EricPresident, COO4F, M, S−10,945$780K617.47K
2024-10-20Kumar RakhiCAO4F−956$0208.37K
2024-10-20Gline MatthewDir, CEO4F−10,945$017.36M
2024-09-28Pulik RichardCFO4F−2,340$0281.28K
2024-09-25Qvt Financial LpDirector by Deputization4S−926,000$10.9M65.79M
2024-09-24Manchester Keith SDir4S−503,000$5.9M1.28M
2024-09-24Gold Daniel AllenDir4S−4,426,000$51.8M28.62M
2024-09-20Kumar RakhiCAO4F, M, S−3,087$2M209.32K
2024-09-20Gline MatthewDir, CEO4F, J, M, S−942,741$23.4M17.37M
2024-09-20Pulik RichardCFO4F−2,129$0283.62K
2024-09-20Venker EricPresident, COO4F−10,945$0628.42K
2024-09-12Oren IlanDir4J−3,487$42.3K95.55K
2024-09-12Epperly Melissa B,Dir4J−4,245$51.4K36.42K
2024-09-12Momtazee James CDir4J−3,056$37K92.43K
2024-09-12Gold Daniel AllenDir4J−2,599$31.5K9.95M
2024-09-12Fitzgerald MeghanDir4J−894$10.8K29.38K
2024-09-10Gold Daniel AllenDir4A16,406$09.95M
2024-09-10Manchester Keith SDir4A16,406$01.78M
2024-09-10Epperly Melissa B,Dir4A16,406$040.67K
2024-09-10Fitzgerald MeghanDir4A16,406$030.27K
2024-09-10Oren IlanDir4A16,406$099.04K
2024-09-10Momtazee James CDir4A16,406$095.49K
2024-08-28Pulik RichardCFO4F−2,341$0285.75K
2024-08-20Kumar RakhiCAO4F−958$0212.41K
2024-08-20Venker EricPresident, COO4F−10,947$0639.36K
2024-08-20Gline MatthewDir, CEO4F−10,947$018.31M
2024-07-28Pulik RichardCFO4F−2,341$0288.09K
2024-07-26Gline MatthewDir, CEO4A17,204,821$018.33M
2024-07-26Sukhatme MayukhPres&Chief Investment Officer, Dir4A18,836,547$024.15M
2024-07-26Venker EricPresident, COO4A204,000$0650.31K
2024-07-23Oren IlanDir4A, F2,225$082.63K
2024-07-23Momtazee James CDir4A1,555$079.09K
2024-07-23Epperly Melissa B,Dir4A1,702$024.26K
2024-07-20Gline MatthewDir, CEO4F−10,945$01.12M
2024-07-20Kumar RakhiCAO4F−958$0213.37K
2024-07-20Venker EricPresident, COO4F−10,945$0446.31K
2024-06-28Pulik RichardCFO4F−2,340$0290.43K
2024-06-20Pulik RichardCFO4F−2,129$0290.57K
2024-06-20Kumar RakhiCAO4F−3,087$0212.12K
2024-06-20Venker EricPresident, COO4F−10,945$0457.25K
2024-06-20Gline MatthewDir, CEO4F−10,945$01.13M
2024-05-28Pulik RichardCFO4F−2,341$0292.7K

As insider in other companies

CompanyTicker
Immunovant, Inc.IMVT
Arbutus Biopharma CorporationABUS